content: <html>
  <head>
       <title></title>
  </head>
  <body style="font: 10pt Times New Roman, Times, Serif">
  
  <p style="text-align: center; margin-top: 0; margin-bottom: 0"><b>As filed with the Securities and Exchange Commission on June
  22, 2021</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b>Registration Statement No. 333-_________</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b></b></p>
  
  <!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</div></div><!-- Field: /Rule-Page -->
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&nbsp;</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WASHINGTON, DC 20549</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>
  
  <!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</div></div><!-- Field: /Rule-Page -->
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM S-8</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>REGISTRATION STATEMENT</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNDER THE SECURITIES ACT OF 1933</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>
  
  <p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>
  
  <!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</div></div><!-- Field: /Rule-Page -->
  
  <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CITIUS PHARMACEUTICALS, INC.</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its charter)</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</p>
  
  <p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>
  
  <!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</div></div><!-- Field: /Rule-Page -->
  
  <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>
  
  <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
    <tr>
      <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; width: 49%; padding-right: 1pt; padding-left: 2pt; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nevada</b></font></td>
      <td style="padding-bottom: 1.5pt; vertical-align: top; width: 2%; padding-right: 1pt; padding-left: 2pt; text-align: center">&nbsp;</td>
      <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; width: 49%; padding-right: 1pt; padding-left: 2pt; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>27-3425913</b></font></td></tr>
    <tr>
      <td style="vertical-align: bottom; padding-right: 1.1pt; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State or other jurisdiction <br>
  of incorporation or organization)&nbsp;</font></td>
      <td style="vertical-align: top; text-align: center">&nbsp;</td>
      <td style="vertical-align: top; padding-right: 1.1pt; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S. Employer <br>
  Identification No.)</font></td></tr>
    </table>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&nbsp;</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>11 Commerce Drive, First Floor</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Cranford New Jersey 07016</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address, including zip code, of registrant&#8217;s
  principal executive offices)</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>
  
  <!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</div></div><!-- Field: /Rule-Page -->
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Citius Pharmaceuticals, Inc. 2020 Omnibus Stock
  Incentive Plan</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Citius Pharmaceuticals, Inc. 2021 Omnibus Stock
  Incentive Plan</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Full title of the plan)</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&nbsp;</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Myron Holubiak</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>President and Chief Executive Officer </b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>11 Commerce Drive, First Floor</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Cranford, New Jersey 07016</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(908)-967-6677 </b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name, address, including zip code, and telephone
  number, including area code, of agent for service)</p>
  
  <p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>
  
  <!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</div></div><!-- Field: /Rule-Page -->
  
  <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><i>Copies to:</i></b></p>
  
  <div style="padding: 0in">
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Alexander M. Donaldson, Esq. </b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Lorna A. Knick, Esq. </b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Wyrick Robbins Yates &amp; Ponton LLP </b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>4101 Lake Boone Trail, Suite 300 </b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Raleigh, North Carolina 27607 </b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(919) 781-4000</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>
  
  <!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</div></div><!-- Field: /Rule-Page -->
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>
  
  </div>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant is a large accelerated
  filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of
  &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth
  company&#8221; in Rule 12b-2 of the Exchange Act.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>
  
  <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
    <tr style="vertical-align: bottom">
      <td style="width: 25%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large accelerated filer</font></td>
      <td style="width: 45%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</font></td>
      <td style="width: 1%">&nbsp;</td>
      <td style="width: 23%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated filer</font></td>
      <td style="width: 1%">&nbsp;</td>
      <td style="width: 5%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</font></td></tr>
    <tr style="vertical-align: bottom">
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-accelerated filer</font></td>
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</font></td>
      <td>&nbsp;</td>
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller reporting company</font></td>
      <td>&nbsp;</td>
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</font></td></tr>
    <tr style="vertical-align: bottom">
      <td>&nbsp;</td>
      <td>&nbsp;</td>
      <td>&nbsp;</td>
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging growth company</font></td>
      <td>&nbsp;</td>
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</font></td></tr>
    </table>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If an emerging growth company, indicate by check mark if the Registrant
  has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
  to Section 7(a)(2)(B) of the Securities Act. &#9744;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
  
  
  <!-- Field: Page; Sequence: 1 -->
      <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></div>
      <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
      <!-- Field: /Page -->
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>CALCULATION OF REGISTRATION FEE</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>
  
  <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
    <tr style="vertical-align: bottom">
      <td style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><b>Title
  of Securities to be Registered</b></p></td><td style="padding-bottom: 1.5pt">&nbsp;</td>
      <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Amount</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>to be</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Registered (1)</b></p></td><td style="padding-bottom: 1.5pt">&nbsp;</td><td style="padding-bottom: 1.5pt">&nbsp;</td>
      <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Proposed</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Maximum</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Offering Price</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Per Share (2)</b></p></td><td style="padding-bottom: 1.5pt">&nbsp;</td><td style="padding-bottom: 1.5pt">&nbsp;</td>
      <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Proposed</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Maximum</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Aggregate</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Offering <br>
  Price</b></p></td><td style="padding-bottom: 1.5pt">&nbsp;</td><td style="padding-bottom: 1.5pt">&nbsp;</td>
      <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Amount of</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Registration Fee</b></p></td><td style="padding-bottom: 1.5pt">&nbsp;</td></tr>
    <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
      <td style="width: 52%">Common Stock, $0.001 par value per share</td><td style="width: 1%">&nbsp;</td>
      <td style="width: 1%; text-align: left">&nbsp;</td><td style="width: 9%; text-align: right">10,610,000</td><td style="width: 1%; text-align: left">&nbsp;</td><td style="width: 1%">&nbsp;</td>
      <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">3.60</td><td style="width: 1%; text-align: left">&nbsp;</td><td style="width: 1%">&nbsp;</td>
      <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">38,196,000</td><td style="width: 1%; text-align: left">&nbsp;</td><td style="width: 1%">&nbsp;</td>
      <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">4,167.18</td><td style="width: 1%; text-align: left">&nbsp;</td></tr>
    </table>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>
  
  <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
    <tr style="vertical-align: top">
      <td style="width: 5%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1) </font></td>
      <td style="width: 95%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), this Registration Statement also covers any additional shares of the Registrant&#8217;s common stock that become issuable under the 2020 Omnibus Stock Incentive Plan or the 2021 Omnibus Stock Incentive Plan by reason of any stock dividend, stock split, recapitalization, or other similar transaction that results in an increase in the number of outstanding shares of the Registrant&#8217;s common stock.</font></td></tr>
    <tr style="vertical-align: top">
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2) </font></td>
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated in accordance with Rules 457(c) and (h) of the Securities Act solely for the purpose of calculating the registration fee based upon the average of the high and low prices of the Registrant&#8217;s common stock on the Nasdaq Capital Market on June 17, 2021.</font></td></tr>
    </table>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
  
  <!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</div></div><!-- Field: /Rule-Page -->
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>
  
  
  <!-- Field: Page; Sequence: 2 -->
      <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></div>
      <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
      <!-- Field: /Page -->
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>PART I</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS
  </b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&nbsp;</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
  1. Plan Information.</b></font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Information required by Item 1 is included in documents that will be
  sent or given by Citius Pharmaceuticals, Inc. (the &#8220;Registrant&#8221;) to participants in the plans covered by this Registration
  Statement pursuant to Rule 428(b)(1) of the Securities Act.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
  2. Registrant Information and Employee Plan Annual Information.</b></font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The written statement required by Item 2 is included in documents that
  will be sent or given by the Registrant to participants in the plans covered by this Registration Statement pursuant to Rule 428(b)(1)
  of the Securities Act.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>
  
  <!-- Field: Page; Sequence: 3 -->
      <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin: 0pt">&#160;</p></div>
      <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
      <!-- Field: /Page -->
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>PART II</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&nbsp;</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
  </b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
  3. Incorporation of Documents by Reference.</b></font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following documents previously filed by the Registrant with the
  Securities and Exchange Commission (the &#8220;Commission&#8221;) are incorporated herein by reference:</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(a) The Registrant&#8217;s Annual Report on Form 10-K for the fiscal
  year ended September 30, 2020, filed with the Commission pursuant to Section 13(a) of the Securities Exchange Act of 1934, as amended
  (the &#8220;Exchange Act&#8221;) on December 16, 2020;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(b) The Registrant&#8217;s Quarterly Report on Form 10-Q for the fiscal
  quarter ended December 31, 2020, filed with the Commission pursuant to Section 13(a) of the Exchange Act on February 11, 2021;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(c) The Registrant&#8217;s Quarterly Report on Form 10-Q for the fiscal
  quarter ended March 31, 2021, filed with the Commission pursuant to Section 13(a) of the Exchange Act on May 13, 2021;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d) The Registrant&#8217;s Current Reports on Form 8-K filed with the
  Commission pursuant to Section 13(a) of the Exchange Act on October 9,&nbsp;October 26,&nbsp;November 30,&nbsp;December 8&nbsp;and&nbsp;December
  9, 2020, and&nbsp;January 11,&nbsp;January 27,&nbsp;February 9,&nbsp;February 16&nbsp;(but not Item 7.01),&nbsp;February 19, May 24, June
  6, June 8, and June 22 (Form 8-K/A), 2021; and</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(b) The description of the Registrant&#8217;s common stock contained
  in the Registrant&#8217;s Registration Statement on Form S-1 filed with the Commission on April 20, 2017, pursuant to the Securities Act
  of 1933, as amended (the &#8220;Securities Act&#8221;), which description is incorporated by reference into the Form 8-A filed with the
  Commission on July 28, 2017, pursuant to the Exchange Act and any amendment or report filed for the purpose of updating such description.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">All documents filed, but not furnished, by the Registrant pursuant
  to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act after the date hereof and prior to the filing of a post-effective amendment
  that indicates that all securities offered under this Registration Statement have been sold or which deregisters all securities then remaining
  unsold shall be deemed to be incorporated by reference herein and to be a part hereof from the date of filing of such documents. In no
  event, however, will any of the information, including exhibits, that the Registrant discloses under Item 2.02 and Item 7.01 of any report
  on Form 8-K that has been or may be, from time to time, furnished to the Commission, be incorporated by reference into or otherwise become
  a part of this Registration Statement.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Any statement contained in a document incorporated by reference herein
  shall be deemed to be modified or superseded for purposes hereof to the extent that a statement contained herein (or in any other subsequently
  filed document that also is or is deemed to be incorporated by reference herein) modifies or supersedes such statement. Any statement
  so modified or superseded shall not be deemed to constitute a part hereof except as so modified or superseded.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
  4. Description of Securities.</b></font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&nbsp;</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Not applicable. The class of securities to be offered is registered
  under Section 12 of the Exchange Act.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
  
  <!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 -->
      <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></div>
      <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
      <!-- Field: /Page -->
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
  5. Interests of Named Experts and Counsel.</b></font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Not applicable.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
  6. Indemnification of Directors and Officers.</b></font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Neither the Registrant&#8217;s Articles of Incorporation nor Bylaws
  prevent the Registrant from indemnifying its officers, directors and agents to the extent permitted under the Nevada Revised Statute (&#8220;NRS&#8221;).
  NRS Section 78.7502 provides that a corporation shall indemnify any director, officer, employee or agent of a corporation against expenses,
  including attorneys&#8217; fees, actually and reasonably incurred by him or her in connection with any the defense to the extent that
  a director, officer, employee or agent of a corporation has been successful on the merits or otherwise in defense of any action, suit
  or proceeding referred to Section 78.7502(1) or 78.7502(2), or in defense of any claim, issue or matter therein.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">NRS Section 78.7502(1) provides that a corporation may indemnify any
  person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether
  civil, criminal, administrative or investigative, except an action by or in the right of the corporation, by reason of the fact that he
  or she is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as
  a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses,
  including attorneys&#8217; fees, judgments, fines and amounts paid in settlement actually and reasonably incurred by him or her in connection
  with the action, suit or proceeding if he or she: (a) is not liable pursuant to NRS 78.138; or (b) acted in good faith and in a manner
  which he or she reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal
  action or proceeding, had no reasonable cause to believe his or her conduct was unlawful.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">NRS Section 78.7502(2) provides that a corporation may indemnify any
  person who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit by or in the right
  of the corporation to procure a judgment in its favor by reason of the fact that he or she is or was a director, officer, employee or
  agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another
  corporation, partnership, joint venture, trust or other enterprise against expenses, including amounts paid in settlement and attorneys&#8217;
  fees actually and reasonably incurred by him or her in connection with the defense or settlement of the action or suit if he or she: (a)
  is not liable pursuant to NRS Section 78.138; or (b) acted in good faith and in a manner which he or she reasonably believed to be in
  or not opposed to the best interests of the corporation. Indemnification may not be made for any claim, issue or matter as to which such
  a person has been adjudged by a court of competent jurisdiction, after exhaustion of all appeals there from, to be liable to the corporation
  or for amounts paid in settlement to the corporation, unless and only to the extent that the court in which the action or suit was brought
  or other court of competent jurisdiction determines upon application that in view of all the circumstances of the case, the person is
  fairly and reasonably entitled to indemnity for such expenses as the court deems proper.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">NRS Section 78.747 provides that except as otherwise provided by specific
  statute, no director or officer of a corporation is individually liable for a debt or liability of the corporation, unless the director
  or officer acts as the alter ego of the corporation. The court as a matter of law must determine the question of whether a director or
  officer acts as the alter ego of a corporation.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif">Insofar as
  indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling the Registrant
  pursuant to the foregoing provisions, the Registrant has been informed that, in the opinion of the Commission, such indemnification is
  against public policy as expressed in the Securities Act and is therefore unenforceable. In the event that a claim for indemnification
  against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling
  person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling
  person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been
  settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by the Registrant
  is against public policy as expressed hereby in the Securities Act and the Registrant will be governed by the final adjudication of such
  issue.</font>&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
  7. Exemption From Registration Claimed.</b></font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Not applicable.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
  
  <!-- Field: Page; Sequence: 5; Value: 1 -->
      <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></div>
      <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
      <!-- Field: /Page -->
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
  8. Exhibits.</b></font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following exhibits are filed as part of this Registration Statement:</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>
  
  <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
    <tr style="vertical-align: top">
      <td style="border-bottom: Black 1.5pt solid; width: 7%; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit <br>
  No.</font></td>
      <td style="padding-bottom: 1.5pt; width: 1%; text-align: center">&nbsp;</td>
      <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; width: 50%; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Description</font></td>
      <td style="padding-bottom: 1.5pt; width: 1%; text-align: center">&nbsp;</td>
      <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; width: 11%; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form</font></td>
      <td style="padding-bottom: 1.5pt; width: 1%; text-align: center">&nbsp;</td>
      <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; width: 10%; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filing Date</font></td>
      <td style="padding-bottom: 1.5pt; width: 1%; text-align: center">&nbsp;</td>
      <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; width: 10%; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit</font></td>
      <td style="padding-bottom: 1.5pt; width: 1%; text-align: center">&nbsp;</td>
      <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; width: 7%; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed herewith</font></td></tr>
    <tr style="vertical-align: top">
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td></tr>
    <tr style="vertical-align: top; background-color: rgb(204,238,255)">
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506251/000147793214005060/citius_ex102.htm">Form of Registration Rights Agreement between the Purchasers named therein and Citius Pharmaceuticals Holdings, Inc., dated September 12, 2014.</a></font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9/18/2014</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td></tr>
    <tr style="vertical-align: top; background-color: White">
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506251/000147793215007801/ctxr_ex1012.htm">Placement Agent&#8217;s Unit Warrant in favor of Merriman Capital, Inc., dated September 12, 2014.</a></font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1/A</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/29/2015</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td></tr>
    <tr style="vertical-align: top; background-color: rgb(204,238,255)">
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506251/000147793214005060/citius_ex103.htm">Form of Investor Warrant, dated September 12, 2014</a></font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9/18/2014</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td></tr>
    <tr style="vertical-align: top; background-color: White">
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506251/000147793217002308/ctxr_ex104.htm">Form of Common Stock Purchase Warrant, dated May 10, 2017.</a></font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Q</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/15/2017</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td></tr>
    <tr style="vertical-align: top; background-color: rgb(204,238,255)">
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506251/000147793217003655/ctxr_ex41.htm">Warrant Agent Agreement dated August 3, 2017 between Citius Pharmaceuticals, Inc. and VStock Transfer, LLC.</a></font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/4/2017</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td></tr>
    <tr style="vertical-align: top; background-color: White">
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506251/000147793217003655/ctxr_ex42.htm">Form of Representative&#8217;s Warrant, dated August 3, 2017.</a></font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/4/2017</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td></tr>
    <tr style="vertical-align: top; background-color: rgb(204,238,255)">
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506251/000121390017013395/f8k1217ex4-1_citiuspharma.htm">Form of Investor Warrant, dated December 15, 2017.</a></font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/19/2017</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td></tr>
    <tr style="vertical-align: top; background-color: White">
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506251/000121390017013395/f8k1217ex4-2_citiuspharma.htm">Form of Placement Agent Warrant, dated December 15, 2017.</a></font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/19/2017</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td></tr>
    <tr style="vertical-align: top; background-color: rgb(204,238,255)">
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506251/000121390018003674/f8k032818ex4-1_citiuspharma.htm">Form of Investor Warrant, dated March 28, 2018.</a></font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/29/2018</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td></tr>
    <tr style="vertical-align: top; background-color: White">
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506251/000121390018003674/f8k032818ex4-2_citiuspharma.htm">Form of Placement Agent Warrant, dated March 28, 2018.</a></font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/29/2018</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td></tr>
    <tr style="vertical-align: top; background-color: rgb(204,238,255)">
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.11</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506251/000121390018010840/f8k081318ex4-1_citiuspharma.htm">Form of Common Stock Purchase Warrant, dated August 13, 2018.</a></font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/13/2018</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td></tr>
    <tr style="vertical-align: top; background-color: White">
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.12</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506251/000121390018010840/f8k081318ex4-2_citiuspharma.htm">Form of Pre-Funded Common Stock Purchase Warrant, dated August 13, 2018.</a></font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/13/2018</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td></tr>
    <tr style="vertical-align: top; background-color: rgb(204,238,255)">
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.13</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506251/000121390018010840/f8k081318ex4-3_citiuspharma.htm">Form of Underwriter&#8217;s Common Stock Purchase Warrant, dated August 13, 2018.</a></font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/13/2018</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td></tr>
    <tr style="vertical-align: top; background-color: White">
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.14</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506251/000121390019005717/f8k040119ex4-1_citiupharma.htm">Form of Investor Warrant, dated April 3, 2019.</a></font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/3/2019</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td></tr>
    <tr style="vertical-align: top; background-color: rgb(204,238,255)">
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.15</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506251/000121390019005717/f8k040119ex4-2_citiupharma.htm">Form of Placement Agent Warrant, dated April 3, 2019.</a></font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/3/2019</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td></tr>
    <tr style="vertical-align: top; background-color: White">
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.16</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506251/000121390019019191/f8k0919ex4-1_citiuspharma.htm">Form of Common Stock Purchase Warrant issued on September 27, 2019.</a></font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9/27/2019</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td></tr>
    <tr style="vertical-align: top; background-color: rgb(204,238,255)">
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.17</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506251/000121390019019191/f8k0919ex4-2_citiuspharma.htm">Form of Pre-Funded Common Stock Purchase Warrant issued on September 27, 2019.</a></font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9/27/2019</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td></tr>
    <tr style="vertical-align: top; background-color: White">
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.18</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506251/000121390019019191/f8k0919ex4-3_citiuspharma.htm">Form of Underwriter&#8217;s Common Stock Purchase Warrant issued on September 27, 2019.</a></font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9/27/2019</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td></tr>
    <tr style="vertical-align: top; background-color: rgb(204,238,255)">
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.19</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506251/000121390020004257/f8k0220ex4-1_citiuspharma.htm">Form of Investor Warrant issued on February 19, 2020.</a></font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/19/2020</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td></tr>
    <tr style="vertical-align: top; background-color: White">
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.20</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506251/000121390020004257/f8k0220ex4-2_citiuspharma.htm">Form of Placement Agent Warrant issued on February 19, 2020.</a></font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/19/2020</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td></tr>
    <tr style="vertical-align: top; background-color: rgb(204,238,255)">
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.21</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506251/000121390020012809/ea0121848ex4-1_citiuspharma.htm">Form of Investor Warrant issued May 18, 2020.</a></font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/18/2020</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td></tr>
    <tr style="vertical-align: top; background-color: White">
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.22</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506251/000121390020012809/ea0121848ex4-2_citiuspharma.htm">Form of Placement Agent Warrant issued May 18, 2020.</a></font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/18/2020</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td></tr>
    <tr style="vertical-align: top; background-color: rgb(204,238,255)">
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.23</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506251/000121390020021164/ea125100ex4-1_citius.htm">Form of Underwriter Warrant issued August 10, 2020.</a></font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/10/2020</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td></tr>
    <tr style="vertical-align: top; background-color: White">
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.24</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506251/000121390021004622/ea133853ex4-1_citius.htm">Form of Investor Warrant issued January 27, 2021.</a></font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/27/2021</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td></tr>
    <tr style="vertical-align: top; background-color: rgb(204,238,255)">
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.25</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506251/000121390021004622/ea133853ex4-2_citius.htm">Form of Placement Agent Warrant issued January 27, 2021.</a></font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/27/2021</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td></tr>
    <tr style="vertical-align: top; background-color: White">
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.26</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506251/000121390021004622/ea133853ex4-3_citius.htm">Registration Rights Agreement, dated January 24, 2021, by and among Citius Pharmaceuticals, Inc. and the investors signatory thereto.</a></font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/27/2021</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td></tr>
    <tr style="vertical-align: top; background-color: rgb(204,238,255)">
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.27</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506251/000121390021010620/ea135915ex4-1_citiuspharma.htm">Form of Investor Warrant issued February 19, 2021.</a></font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/19/2021</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td></tr>
    <tr style="vertical-align: top; background-color: White">
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.28</font></td>
      <td>&nbsp;</td>
      <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506251/000121390021010620/ea135915ex4-2_citiuspharma.htm">Form of Placement Agent Warrant issued February 19, 2021.</a></font></td>
      <td>&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/19/2021</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td></tr>
    <tr style="vertical-align: top; background-color: rgb(204,238,255)">
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</font></td>
      <td>&nbsp;</td>
      <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea143027ex5-1_citiuspharma.htm">Opinion of Wyrick Robbins Yates &amp; Ponton LLP.</a></font></td>
      <td>&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</font></td></tr>
    <tr style="vertical-align: top; background-color: White">
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</font></td>
      <td>&nbsp;</td>
      <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea143027ex23-1_citiuspharma.htm">Consent of Wolf &amp; Company, P.C.</a></font></td>
      <td>&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</font></td></tr>
    <tr style="vertical-align: top; background-color: rgb(204,238,255)">
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2</font></td>
      <td>&nbsp;</td>
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea143027ex5-1_citiuspharma.htm">Consent of Wyrick Robbins Yates &amp; Ponton LLP (included in Exhibit 5.1).</a></font></td>
      <td>&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</font></td></tr>
    <tr style="vertical-align: top; background-color: White">
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1</font></td>
      <td>&nbsp;</td>
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#poa_001">Power of Attorney (included on page S-1).</a></font></td>
      <td>&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</font></td></tr>
    <tr style="vertical-align: top; background-color: rgb(204,238,255)">
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</font></td>
      <td>&nbsp;</td>
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506251/000121390019026703/def14a1219_citiuspharma.htm">Citius Pharmaceuticals, Inc. 2020 Omnibus Stock Incentive Plan.</a> &nbsp;</font></td>
      <td>&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule 14A</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/20/2019</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Appendix A</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td></tr>
    <tr style="vertical-align: top; background-color: White">
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.2</font></td>
      <td>&nbsp;</td>
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506251/000121390020003577/f10q1219ex10-2_citiuspharma.htm">Form of Notice of Stock Option Grant and Stock Option Award Agreement</a></font></td>
      <td>&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Q</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/13/2020</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td></tr>
    <tr style="vertical-align: top; background-color: rgb(204,238,255)">
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.3</font></td>
      <td>&nbsp;</td>
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1506251/000121390021021181/ea139206-def14a_citiuspharma.htm">Citius Pharmaceuticals, Inc. 2021 Omnibus Stock Incentive Plan.</a> &nbsp;</font></td>
      <td>&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule 14A</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/12/2021</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Appendix B</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td></tr>
    <tr style="vertical-align: top; background-color: White">
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.4</font></td>
      <td>&nbsp;</td>
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea143027ex99-4_citiuspharma.htm">Form of Notice of Stock Option Grant and Stock Option Award Agreement</a></font></td>
      <td>&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</font></td></tr>
    </table>
  <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></p>
  
  <!-- Field: Page; Sequence: 6; Value: 1 -->
      <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></div>
      <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
      <!-- Field: /Page -->
  
  <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
  9. Undertakings.</b></font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&nbsp;</b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(a) The undersigned Registrant hereby undertakes:</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(1) To file, during any period in which offers or sales are being made,
  a post-effective amendment to this Registration Statement:</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>
  
  <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
    <tr style="vertical-align: top">
      <td style="width: 5%">&nbsp;</td>
      <td style="width: 5%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) &nbsp;</font></td>
      <td style="width: 90%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To include any prospectus required by Section 10(a)(3) of the Securities Act;</font></td></tr>
    <tr style="vertical-align: top">
      <td>&nbsp;</td>
      <td>&nbsp;</td>
      <td>&nbsp;</td></tr>
    <tr style="vertical-align: top">
      <td>&nbsp;</td>
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) &nbsp;</font></td>
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To reflect in the prospectus any facts or events arising after the effective date of this Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in this Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective Registration Statement;</font></td></tr>
    <tr>
      <td>&nbsp;</td>
      <td>&nbsp;</td>
      <td>&nbsp;</td></tr>
    <tr style="vertical-align: top">
      <td>&nbsp;</td>
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) &nbsp;</font></td>
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration Statement;</font></td></tr>
    </table>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>provided</i>, <i>however</i>, that paragraphs (a)(1)(i) and (a)(1)(ii)
  of this section do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained
  in reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that
  are incorporated by reference in the Registration Statement.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(2) That, for the purpose of determining any liability under the Securities
  Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein,
  and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(3) To remove from registration by means of a post-effective amendment
  any of the securities being registered which remain unsold at the termination of the offering.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(b) The undersigned Registrant hereby undertakes that, for purposes
  of determining any liability under the Securities Act, each filing of the Registrant&#8217;s annual report pursuant to Section 13(a) or
  Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan&#8217;s annual report pursuant to Section
  15(d) of the Exchange Act) that is incorporated by reference in the Registration Statement shall be deemed to be a new registration statement
  related to the securities offered therein, and the offering of such securities at the time shall be deemed to be the initial bona fide
  offering thereof.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(h) Insofar as indemnification for liabilities arising under the Securities
  Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise,
  the Registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the
  Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the
  payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful
  defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities
  being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit
  to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities
  Act and will be governed by the final adjudication of such issue.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</p>
  
  
  <!-- Field: Page; Sequence: 7; Value: 1 -->
      <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></div>
      <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
      <!-- Field: /Page -->
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><a name="poa_001"></a>SIGNATURES </b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the requirements of the Securities Act of 1933, the Registrant
  certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this
  Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Cranford, State of New
  Jersey, on the 22nd day of June, 2021.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>
  
  <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
    <tr style="vertical-align: top">
      <td>&nbsp;</td>
      <td colspan="2"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CITIUS PHARMACEUTICALS, INC.</b></font></td></tr>
    <tr>
      <td style="width: 60%">&nbsp;</td>
      <td style="width: 4%">&nbsp;</td>
      <td style="width: 36%">&nbsp;</td></tr>
    <tr>
      <td>&nbsp;</td>
      <td style="vertical-align: top"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</font></td>
      <td style="border-bottom: Black 1.5pt solid; vertical-align: top"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Myron Holubiak</font></td></tr>
    <tr>
      <td>&nbsp;</td>
      <td style="vertical-align: top">&nbsp;</td>
      <td style="vertical-align: bottom"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Myron Holubiak</font></td></tr>
    <tr>
      <td>&nbsp;</td>
      <td style="vertical-align: top">&nbsp;</td>
      <td style="vertical-align: bottom"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">President and Chief Executive Officer</font></td></tr>
    </table>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>POWER OF ATTORNEY </b></p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Each person whose signature appears below constitutes and appoints
  Myron Holubiak and Leonard Mazur, and each of them, his or her true and lawful attorney-in-fact and agent, with full power of substitution
  and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments
  (including post-effective amendments) to this Registration Statement, and to file the same, with all exhibits thereto, and other documents
  in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent full power and authority
  to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and
  purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his substitute
  or substitutes, may lawfully do or cause to be done by virtue hereof.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the requirements of the Securities Act, this registration
  statement has been signed by the following persons in the capacities and on the dates indicated.</p>
  
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>
  
  <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
    <tr style="vertical-align: top">
      <td style="border-bottom: Black 1.5pt solid; width: 27%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Signature</b></font></td>
      <td style="padding-bottom: 1.5pt; width: 1%">&nbsp;</td>
      <td style="border-bottom: Black 1.5pt solid; width: 53%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title</b></font></td>
      <td style="padding-bottom: 1.5pt; width: 1%; text-align: center">&nbsp;</td>
      <td style="border-bottom: Black 1.5pt solid; width: 18%; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date</b></font></td></tr>
    <tr style="vertical-align: top">
      <td>&nbsp;</td>
      <td>&nbsp;</td>
      <td>&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td></tr>
    <tr>
      <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Myron Holubiak</font></td>
      <td style="vertical-align: top; text-align: justify">&nbsp;</td>
      <td style="vertical-align: top"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">President and Chief Executive Officer </font></td>
      <td style="vertical-align: top; text-align: center">&nbsp;</td>
      <td style="vertical-align: top; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 22, 2021</font></td></tr>
    <tr style="vertical-align: top">
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Myron Holubiak</font></td>
      <td style="text-align: justify">&nbsp;</td>
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Executive Officer)</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td></tr>
    <tr style="vertical-align: top">
      <td>&nbsp;</td>
      <td style="text-align: justify">&nbsp;</td>
      <td>&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td></tr>
    <tr>
      <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><u style="text-decoration: none">/s/ Jaime Bartushak</u></font></td>
      <td style="vertical-align: top; text-align: justify">&nbsp;</td>
      <td style="vertical-align: top"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer and Chief Accounting Officer </font></td>
      <td style="vertical-align: top; text-align: center">&nbsp;</td>
      <td style="vertical-align: top; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 22, 2021</font></td></tr>
    <tr style="vertical-align: top">
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jaime Bartushak</font></td>
      <td style="text-align: justify">&nbsp;</td>
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Financial Officer and Principal Accounting Officer)</font></td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td></tr>
    <tr style="vertical-align: top">
      <td>&nbsp;</td>
      <td>&nbsp;</td>
      <td>&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td></tr>
    <tr>
      <td style="border-bottom: Black 1.5pt solid"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Leonard Mazur</font></td>
      <td style="vertical-align: top">&nbsp;</td>
      <td style="vertical-align: top"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive Chairman, Board of Directors</font></td>
      <td style="vertical-align: top; text-align: center">&nbsp;</td>
      <td style="vertical-align: top; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 22, 2021</font></td></tr>
    <tr style="vertical-align: top">
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leonard Mazur</font></td>
      <td>&nbsp;</td>
      <td>&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td></tr>
    <tr style="vertical-align: top">
      <td style="text-align: justify">&nbsp;</td>
      <td>&nbsp;</td>
      <td>&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td></tr>
    <tr>
      <td style="border-bottom: Black 1.5pt solid"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Suren Dutia</font></td>
      <td style="vertical-align: top">&nbsp;</td>
      <td style="vertical-align: top"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</font></td>
      <td style="vertical-align: top; text-align: center">&nbsp;</td>
      <td style="vertical-align: top; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 22, 2021</font></td></tr>
    <tr style="vertical-align: top">
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Suren Dutia</font></td>
      <td>&nbsp;</td>
      <td>&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td></tr>
    <tr style="vertical-align: top">
      <td style="text-align: justify">&nbsp;</td>
      <td>&nbsp;</td>
      <td>&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td></tr>
    <tr>
      <td style="border-bottom: Black 1.5pt solid"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Carol Webb</font></td>
      <td style="vertical-align: top">&nbsp;</td>
      <td style="vertical-align: top"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</font></td>
      <td style="vertical-align: top; text-align: center">&nbsp;</td>
      <td style="vertical-align: top; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 22, 2021</font></td></tr>
    <tr style="vertical-align: top">
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carol Webb</font></td>
      <td>&nbsp;</td>
      <td>&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td></tr>
    <tr style="vertical-align: top">
      <td style="text-align: justify">&nbsp;</td>
      <td>&nbsp;</td>
      <td>&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td></tr>
    <tr>
      <td style="border-bottom: Black 1.5pt solid"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ William Kane</font></td>
      <td style="vertical-align: top">&nbsp;</td>
      <td style="vertical-align: top"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</font></td>
      <td style="vertical-align: top; text-align: center">&nbsp;</td>
      <td style="vertical-align: top; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 22, 2021</font></td></tr>
    <tr style="vertical-align: top">
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr. William Kane</font></td>
      <td>&nbsp;</td>
      <td>&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td></tr>
    <tr style="vertical-align: top">
      <td style="text-align: justify">&nbsp;</td>
      <td>&nbsp;</td>
      <td>&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td></tr>
    <tr>
      <td style="border-bottom: Black 1.5pt solid"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Howard Safir</font></td>
      <td style="vertical-align: top">&nbsp;</td>
      <td style="vertical-align: top"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</font></td>
      <td style="vertical-align: top; text-align: center">&nbsp;</td>
      <td style="vertical-align: top; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 22, 2021</font></td></tr>
    <tr style="vertical-align: top">
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Howard Safir</font></td>
      <td>&nbsp;</td>
      <td>&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td></tr>
    <tr style="vertical-align: top">
      <td style="text-align: justify">&nbsp;</td>
      <td>&nbsp;</td>
      <td>&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td></tr>
    <tr>
      <td style="border-bottom: Black 1.5pt solid"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Eugene Holuka</font></td>
      <td style="vertical-align: top">&nbsp;</td>
      <td style="vertical-align: top"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</font></td>
      <td style="vertical-align: top; text-align: center">&nbsp;</td>
      <td style="vertical-align: top; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 22, 2021</font></td></tr>
    <tr style="vertical-align: top">
      <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr. Eugene Holuka</font></td>
      <td>&nbsp;</td>
      <td>&nbsp;</td>
      <td style="text-align: center">&nbsp;</td>
      <td style="text-align: center">&nbsp;</td></tr>
    </table>
  <p style="margin: 0">&nbsp;</p>
  
  <p style="margin: 0">&nbsp;</p>
  
  <p style="text-align: center; margin-top: 0; margin-bottom: 0">II-5</p>
  
  <p style="margin: 0"></p>
  
  <!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</div></div><!-- Field: /Rule-Page -->
  
  <p style="margin: 0"></p>
  
  </body>
  </html>
metadata_documents: [{"type": "S-8", "sequence": "1", "filename": "ea143027-s8_citiuspharma.htm", "description": "REGISTRATION STATEMENT", "secsgml_size_bytes": 98907}]
metadata_filer: {"company-data": {"conformed-name": "Citius Pharmaceuticals, Inc.", "cik": "0001506251", "assigned-sic": "2834", "irs-number": "273425913", "state-of-incorporation": "NV", "fiscal-year-end": "0930"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-257282", "film-number": "211035826"}, "business-address": {"street1": "11 COMMERCE DRIVE", "street2": "1ST FLOOR", "city": "CRANFORD", "state": "NJ", "zip": "07016", "phone": "(908) 967-6676"}, "mail-address": {"street1": "11 COMMERCE DRIVE", "street2": "1ST FLOOR", "city": "CRANFORD", "state": "NJ", "zip": "07016"}, "former-company": [{"former-conformed-name": "Trail One, Inc.", "date-changed": "20110314"}, {"former-conformed-name": "TrailOne, Inc.", "date-changed": "20101119"}]}
text: As filed with the Securities and Exchange Commission on June
  22, 2021
  Registration Statement No. 333-_________
  UNITED STATES
  SECURITIES AND EXCHANGE COMMISSION
  WASHINGTON, DC 20549
  FORM S-8
  REGISTRATION STATEMENT
  UNDER THE SECURITIES ACT OF 1933
  CITIUS PHARMACEUTICALS, INC.
  (Exact name of registrant as specified in its charter)
  Nevada
  27-3425913
  (State or other jurisdiction
  of incorporation or organization)
  (I.R.S. Employer
  Identification No.)
  11 Commerce Drive, First Floor
  Cranford New Jersey 07016
  (Address, including zip code, of registrant's
  principal executive offices)
  Citius Pharmaceuticals, Inc. 2020 Omnibus Stock
  Incentive Plan
  Citius Pharmaceuticals, Inc. 2021 Omnibus Stock
  Incentive Plan
  (Full title of the plan)
  Myron Holubiak
  President and Chief Executive Officer
  11 Commerce Drive, First Floor
  Cranford, New Jersey 07016
  (908)-967-6677
  (Name, address, including zip code, and telephone
  number, including area code, of agent for service)
  Copies to:
  Alexander M. Donaldson, Esq.
  Lorna A. Knick, Esq.
  Wyrick Robbins Yates & Ponton LLP
  4101 Lake Boone Trail, Suite 300
  Raleigh, North Carolina 27607
  (919) 781-4000
  Indicate by check mark whether the registrant is a large accelerated
  filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of
  "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth
  company" in Rule 12b-2 of the Exchange Act.
  Large accelerated filer
  ☐
  Accelerated filer
  ☐
  Non-accelerated filer
  ☒
  Smaller reporting company
  ☒
  Emerging growth company
  ☐
  If an emerging growth company, indicate by check mark if the Registrant
  has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
  to Section 7(a)(2)(B) of the Securities Act. ☐
  CALCULATION OF REGISTRATION FEE
  Title
  of Securities to be Registered
  Amount
  to be
  Registered (1)
  Proposed
  Maximum
  Offering Price
  Per Share (2)
  Proposed
  Maximum
  Aggregate
  Offering
  Price
  Amount of
  Registration Fee
  Common Stock, $0.001 par value per share
  10,610,000
  $
  3.60
  $
  38,196,000
  $
  4,167.18
  (1)
  Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the "Securities Act"), this Registration Statement also covers any additional shares of the Registrant's common stock that become issuable under the 2020 Omnibus Stock Incentive Plan or the 2021 Omnibus Stock Incentive Plan by reason of any stock dividend, stock split, recapitalization, or other similar transaction that results in an increase in the number of outstanding shares of the Registrant's common stock.
  (2)
  Estimated in accordance with Rules 457(c) and (h) of the Securities Act solely for the purpose of calculating the registration fee based upon the average of the high and low prices of the Registrant's common stock on the Nasdaq Capital Market on June 17, 2021.
  PART I
  INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS
  Item
  1. Plan Information.
  Information required by Item 1 is included in documents that will be
  sent or given by Citius Pharmaceuticals, Inc. (the "Registrant") to participants in the plans covered by this Registration
  Statement pursuant to Rule 428(b)(1) of the Securities Act.
  Item
  2. Registrant Information and Employee Plan Annual Information.
  The written statement required by Item 2 is included in documents that
  will be sent or given by the Registrant to participants in the plans covered by this Registration Statement pursuant to Rule 428(b)(1)
  of the Securities Act.
  PART II
  INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
  Item
  3. Incorporation of Documents by Reference.
  The following documents previously filed by the Registrant with the
  Securities and Exchange Commission (the "Commission") are incorporated herein by reference:
  (a) The Registrant's Annual Report on Form 10-K for the fiscal
  year ended September 30, 2020, filed with the Commission pursuant to Section 13(a) of the Securities Exchange Act of 1934, as amended
  (the "Exchange Act") on December 16, 2020;
  (b) The Registrant's Quarterly Report on Form 10-Q for the fiscal
  quarter ended December 31, 2020, filed with the Commission pursuant to Section 13(a) of the Exchange Act on February 11, 2021;
  (c) The Registrant's Quarterly Report on Form 10-Q for the fiscal
  quarter ended March 31, 2021, filed with the Commission pursuant to Section 13(a) of the Exchange Act on May 13, 2021;
  (d) The Registrant's Current Reports on Form 8-K filed with the
  Commission pursuant to Section 13(a) of the Exchange Act on October 9, October 26, November 30, December 8 and December
  9, 2020, and January 11, January 27, February 9, February 16 (but not Item 7.01), February 19, May 24, June
  6, June 8, and June 22 (Form 8-K/A), 2021; and
  (b) The description of the Registrant's common stock contained
  in the Registrant's Registration Statement on Form S-1 filed with the Commission on April 20, 2017, pursuant to the Securities Act
  of 1933, as amended (the "Securities Act"), which description is incorporated by reference into the Form 8-A filed with the
  Commission on July 28, 2017, pursuant to the Exchange Act and any amendment or report filed for the purpose of updating such description.
  All documents filed, but not furnished, by the Registrant pursuant
  to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act after the date hereof and prior to the filing of a post-effective amendment
  that indicates that all securities offered under this Registration Statement have been sold or which deregisters all securities then remaining
  unsold shall be deemed to be incorporated by reference herein and to be a part hereof from the date of filing of such documents. In no
  event, however, will any of the information, including exhibits, that the Registrant discloses under Item 2.02 and Item 7.01 of any report
  on Form 8-K that has been or may be, from time to time, furnished to the Commission, be incorporated by reference into or otherwise become
  a part of this Registration Statement.
  Any statement contained in a document incorporated by reference herein
  shall be deemed to be modified or superseded for purposes hereof to the extent that a statement contained herein (or in any other subsequently
  filed document that also is or is deemed to be incorporated by reference herein) modifies or supersedes such statement. Any statement
  so modified or superseded shall not be deemed to constitute a part hereof except as so modified or superseded.
  Item
  4. Description of Securities.
  Not applicable. The class of securities to be offered is registered
  under Section 12 of the Exchange Act.
  II-
  1
  Item
  5. Interests of Named Experts and Counsel.
  Not applicable.
  Item
  6. Indemnification of Directors and Officers.
  Neither the Registrant's Articles of Incorporation nor Bylaws
  prevent the Registrant from indemnifying its officers, directors and agents to the extent permitted under the Nevada Revised Statute ("NRS").
  NRS Section 78.7502 provides that a corporation shall indemnify any director, officer, employee or agent of a corporation against expenses,
  including attorneys' fees, actually and reasonably incurred by him or her in connection with any the defense to the extent that
  a director, officer, employee or agent of a corporation has been successful on the merits or otherwise in defense of any action, suit
  or proceeding referred to Section 78.7502(1) or 78.7502(2), or in defense of any claim, issue or matter therein.
  NRS Section 78.7502(1) provides that a corporation may indemnify any
  person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether
  civil, criminal, administrative or investigative, except an action by or in the right of the corporation, by reason of the fact that he
  or she is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as
  a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses,
  including attorneys' fees, judgments, fines and amounts paid in settlement actually and reasonably incurred by him or her in connection
  with the action, suit or proceeding if he or she: (a) is not liable pursuant to NRS 78.138; or (b) acted in good faith and in a manner
  which he or she reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal
  action or proceeding, had no reasonable cause to believe his or her conduct was unlawful.
  NRS Section 78.7502(2) provides that a corporation may indemnify any
  person who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit by or in the right
  of the corporation to procure a judgment in its favor by reason of the fact that he or she is or was a director, officer, employee or
  agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another
  corporation, partnership, joint venture, trust or other enterprise against expenses, including amounts paid in settlement and attorneys'
  fees actually and reasonably incurred by him or her in connection with the defense or settlement of the action or suit if he or she: (a)
  is not liable pursuant to NRS Section 78.138; or (b) acted in good faith and in a manner which he or she reasonably believed to be in
  or not opposed to the best interests of the corporation. Indemnification may not be made for any claim, issue or matter as to which such
  a person has been adjudged by a court of competent jurisdiction, after exhaustion of all appeals there from, to be liable to the corporation
  or for amounts paid in settlement to the corporation, unless and only to the extent that the court in which the action or suit was brought
  or other court of competent jurisdiction determines upon application that in view of all the circumstances of the case, the person is
  fairly and reasonably entitled to indemnity for such expenses as the court deems proper.
  NRS Section 78.747 provides that except as otherwise provided by specific
  statute, no director or officer of a corporation is individually liable for a debt or liability of the corporation, unless the director
  or officer acts as the alter ego of the corporation. The court as a matter of law must determine the question of whether a director or
  officer acts as the alter ego of a corporation.
  Insofar as
  indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling the Registrant
  pursuant to the foregoing provisions, the Registrant has been informed that, in the opinion of the Commission, such indemnification is
  against public policy as expressed in the Securities Act and is therefore unenforceable. In the event that a claim for indemnification
  against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling
  person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling
  person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been
  settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by the Registrant
  is against public policy as expressed hereby in the Securities Act and the Registrant will be governed by the final adjudication of such
  issue.
  Item
  7. Exemption From Registration Claimed.
  Not applicable.
  II-
  2
  Item
  8. Exhibits.
  The following exhibits are filed as part of this Registration Statement:
  Exhibit
  No.
  Description
  Form
  Filing Date
  Exhibit
  Filed herewith
  4.1
  Form of Registration Rights Agreement between the Purchasers named therein and Citius Pharmaceuticals Holdings, Inc., dated September 12, 2014.
  8-K
  9/18/2014
  10.2
  4.2
  Placement Agent's Unit Warrant in favor of Merriman Capital, Inc., dated September 12, 2014.
  S-1/A
  12/29/2015
  10.12
  4.3
  Form of Investor Warrant, dated September 12, 2014
  8-K
  9/18/2014
  10.3
  4.4
  Form of Common Stock Purchase Warrant, dated May 10, 2017.
  10-Q
  5/15/2017
  10.4
  4.5
  Warrant Agent Agreement dated August 3, 2017 between Citius Pharmaceuticals, Inc. and VStock Transfer, LLC.
  8-K
  8/4/2017
  4.1
  4.6
  Form of Representative's Warrant, dated August 3, 2017.
  8-K
  8/4/2017
  4.2
  4.7
  Form of Investor Warrant, dated December 15, 2017.
  8-K
  12/19/2017
  4.1
  4.8
  Form of Placement Agent Warrant, dated December 15, 2017.
  8-K
  12/19/2017
  4.2
  4.9
  Form of Investor Warrant, dated March 28, 2018.
  8-K
  3/29/2018
  4.1
  4.10
  Form of Placement Agent Warrant, dated March 28, 2018.
  8-K
  3/29/2018
  4.2
  4.11
  Form of Common Stock Purchase Warrant, dated August 13, 2018.
  8-K
  8/13/2018
  4.1
  4.12
  Form of Pre-Funded Common Stock Purchase Warrant, dated August 13, 2018.
  8-K
  8/13/2018
  4.2
  4.13
  Form of Underwriter's Common Stock Purchase Warrant, dated August 13, 2018.
  8-K
  8/13/2018
  4.3
  4.14
  Form of Investor Warrant, dated April 3, 2019.
  8-K
  4/3/2019
  4.1
  4.15
  Form of Placement Agent Warrant, dated April 3, 2019.
  8-K
  4/3/2019
  4.2
  4.16
  Form of Common Stock Purchase Warrant issued on September 27, 2019.
  8-K
  9/27/2019
  4.1
  4.17
  Form of Pre-Funded Common Stock Purchase Warrant issued on September 27, 2019.
  8-K
  9/27/2019
  4.2
  4.18
  Form of Underwriter's Common Stock Purchase Warrant issued on September 27, 2019.
  8-K
  9/27/2019
  4.3
  4.19
  Form of Investor Warrant issued on February 19, 2020.
  8-K
  2/19/2020
  4.1
  4.20
  Form of Placement Agent Warrant issued on February 19, 2020.
  8-K
  2/19/2020
  4.2
  4.21
  Form of Investor Warrant issued May 18, 2020.
  8-K
  5/18/2020
  4.1
  4.22
  Form of Placement Agent Warrant issued May 18, 2020.
  8-K
  5/18/2020
  4.2
  4.23
  Form of Underwriter Warrant issued August 10, 2020.
  8-K
  8/10/2020
  4.1
  4.24
  Form of Investor Warrant issued January 27, 2021.
  8-K
  1/27/2021
  4.1
  4.25
  Form of Placement Agent Warrant issued January 27, 2021.
  8-K
  1/27/2021
  4.2
  4.26
  Registration Rights Agreement, dated January 24, 2021, by and among Citius Pharmaceuticals, Inc. and the investors signatory thereto.
  8-K
  1/27/2021
  4.3
  4.27
  Form of Investor Warrant issued February 19, 2021.
  8-K
  2/19/2021
  4.1
  4.28
  Form of Placement Agent Warrant issued February 19, 2021.
  8-K
  2/19/2021
  4.2
  5.1
  Opinion of Wyrick Robbins Yates & Ponton LLP.
  X
  23.1
  Consent of Wolf & Company, P.C.
  X
  23.2
  Consent of Wyrick Robbins Yates & Ponton LLP (included in Exhibit 5.1).
  X
  24.1
  Power of Attorney (included on page S-1).
  X
  99.1
  Citius Pharmaceuticals, Inc. 2020 Omnibus Stock Incentive Plan.
  Schedule 14A
  12/20/2019
  Appendix A
  99.2
  Form of Notice of Stock Option Grant and Stock Option Award Agreement
  10-Q
  2/13/2020
  10.2
  99.3
  Citius Pharmaceuticals, Inc. 2021 Omnibus Stock Incentive Plan.
  Schedule 14A
  4/12/2021
  Appendix B
  99.4
  Form of Notice of Stock Option Grant and Stock Option Award Agreement
  X
  II-
  3
  Item
  9. Undertakings.
  (a) The undersigned Registrant hereby undertakes:
  (1) To file, during any period in which offers or sales are being made,
  a post-effective amendment to this Registration Statement:
  (i)
  To include any prospectus required by Section 10(a)(3) of the Securities Act;
  (ii)
  To reflect in the prospectus any facts or events arising after the effective date of this Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in this Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the "Calculation of Registration Fee" table in the effective Registration Statement;
  (iii)
  To include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration Statement;
  provided
  ,
  however
  , that paragraphs (a)(1)(i) and (a)(1)(ii)
  of this section do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained
  in reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that
  are incorporated by reference in the Registration Statement.
  (2) That, for the purpose of determining any liability under the Securities
  Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein,
  and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
  (3) To remove from registration by means of a post-effective amendment
  any of the securities being registered which remain unsold at the termination of the offering.
  (b) The undersigned Registrant hereby undertakes that, for purposes
  of determining any liability under the Securities Act, each filing of the Registrant's annual report pursuant to Section 13(a) or
  Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan's annual report pursuant to Section
  15(d) of the Exchange Act) that is incorporated by reference in the Registration Statement shall be deemed to be a new registration statement
  related to the securities offered therein, and the offering of such securities at the time shall be deemed to be the initial bona fide
  offering thereof.
  (h) Insofar as indemnification for liabilities arising under the Securities
  Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise,
  the Registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the
  Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the
  payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful
  defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities
  being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit
  to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities
  Act and will be governed by the final adjudication of such issue.
  II-
  4
  SIGNATURES
  Pursuant to the requirements of the Securities Act of 1933, the Registrant
  certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this
  Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Cranford, State of New
  Jersey, on the 22nd day of June, 2021.
  CITIUS PHARMACEUTICALS, INC.
  By:
  /s/ Myron Holubiak
  Myron Holubiak
  President and Chief Executive Officer
  POWER OF ATTORNEY
  Each person whose signature appears below constitutes and appoints
  Myron Holubiak and Leonard Mazur, and each of them, his or her true and lawful attorney-in-fact and agent, with full power of substitution
  and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments
  (including post-effective amendments) to this Registration Statement, and to file the same, with all exhibits thereto, and other documents
  in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent full power and authority
  to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and
  purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his substitute
  or substitutes, may lawfully do or cause to be done by virtue hereof.
  Pursuant to the requirements of the Securities Act, this registration
  statement has been signed by the following persons in the capacities and on the dates indicated.
  Signature
  Title
  Date
  /s/ Myron Holubiak
  President and Chief Executive Officer
  June 22, 2021
  Myron Holubiak
  (Principal Executive Officer)
  /s/ Jaime Bartushak
  Chief Financial Officer and Chief Accounting Officer
  June 22, 2021
  Jaime Bartushak
  (Principal Financial Officer and Principal Accounting Officer)
  /s/ Leonard Mazur
  Executive Chairman, Board of Directors
  June 22, 2021
  Leonard Mazur
  /s/ Suren Dutia
  Director
  June 22, 2021
  Suren Dutia
  /s/ Carol Webb
  Director
  June 22, 2021
  Carol Webb
  /s/ William Kane
  Director
  June 22, 2021
  Dr. William Kane
  /s/ Howard Safir
  Director
  June 22, 2021
  Howard Safir
  /s/ Eugene Holuka
  Director
  June 22, 2021
  Dr. Eugene Holuka
  II-5